South Dakota § 34-20E-2 Prescription drug monitoring program to be established--Medical cannabis qualifying patients.

South Dakota Statutes

§ 34-20E-2 — Prescription drug monitoring program to be established--Medical cannabis qualifying patients.

South Dakota § 34-20E-2

Title 34PUBLIC HEALTH AND SAFETY

Ch. 34-20DPRESCRIPTION DRUG MONITORING PROGRAM

This text of South Dakota § 34-20E-2 (Prescription drug monitoring program to be established--Medical cannabis qualifying patients.) is published on Counsel Stack Legal Research, covering South Dakota primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

S.D. Codified Laws § 34-20E-2 (2026).

Text

The board shall establish and maintain a prescription drug monitoring program to monitor the prescribing and dispensing of all controlled substances. The program shall utilize a central repository, to which each dispenser shall submit, by electronic means, information regarding each prescription dispensed for a controlled substance. The information submitted for each prescription must include specifically identified data elements adopted by the board and contained in the 2011 version of the electronic reporting standard for prescription monitoring programs, version 4.2 of the American Society for Automation in Pharmacy. The program must include the names of qualifying patients who receive a registry identification card, as defined in § 34-20G-1 , submitted by the Department of Health.

Free access — add to your briefcase to read the full text and ask questions with AI

The board shall establish and maintain a prescription drug monitoring program to monitor the prescribing and dispensing of all controlled substances. The program shall utilize a central repository, to which each dispenser shall submit, by electronic means, information regarding each prescription dispensed for a controlled substance. The information submitted for each prescription must include specifically identified data elements adopted by the board and contained in the 2011 version of the electronic reporting standard for prescription monitoring programs, version 4.2 of the American Society for Automation in Pharmacy. The program must include the names of qualifying patients who receive a registry identification card, as defined in § 34-20G-1 , submitted by the Department of Health.